Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
1.990
0.00 (0.00%)
Jul 29, 2026, 4:00 PM EDT - Market closed

[Name] Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, [Name] stock has a consensus rating of "Buy" and an average price target of $8.50. The average 1-year stock price forecast is 327.14% higher than the current stock price, while the lowest is $7.00 (+251.76%) and the highest is $10 (+402.51%).

Price Target: $8.50 (+327.14%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$7.00$8.50$8.50$10
Change+251.76%+327.14%+327.14%+402.51%
* Price targets were last updated on Apr 22, 2026.

Analyst Ratings

The average analyst rating for [Name] stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26Jul '26
Strong Buy0001
Buy1111
Hold0000
Sell0000
Strong Sell0000
Total1112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Buy
Maintains
$10
BuyMaintains$10+402.51%Apr 22, 2026

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
----
Operating Income
-3.78M-4.35M-7.82M-10.51M
Net Income
-3.78M-30.36M-8.99M-11.09M
Free Cash Flow
-992.00K505.87K-6.15M
No. Analysts
---2

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-
Avg-
Low-

EPS Growth

EPS Growth20272028
High-
Avg-
Low-